Ghent University Academic Bibliography

Your filters: cql: author="Theeten, Heidi" or (type any "bookEditor issueEditor" and editor="Theeten, Heidi")

Add to list
- Journal Article
- A1
- open access
COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020

Geert Molenberghs, Christel Faes, Johan Verbeeck, Patrick Deboosere, Steven Abrams, Lander Willem, Jan Aerts, Heidi Theeten, Brecht Devleesschauwer (UGent) , Natalia Bustos Sierra, et al.

(2022) EUROSURVEILLANCE. 27(7).
Add to list
- Journal Article
- A1
- open access
How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018

Ine Wouters, Stefanie Desmet, Liesbet Van Heirstraeten, Sereina A Herzog, Philippe Beutels, Jan Verhaegen, Herman Goossens, Pierre Van Damme, Surbhi Malhotra-Kumar, Heidi Theeten, et al.

(2020) EUROSURVEILLANCE. 25(5). p.32-44
Add to list
- Journal Article
- A1
- open access
Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic : perspective from a European country

Geert Molenberghs, Marc Buyse, Steven Abrams, Niel Hens, Philippe Beutels, Christel Faes, Geert Verbeke, Pierre Van Damme, Herman Goossens, Thomas Neyens, et al.

(2020) CONTEMPORARY CLINICAL TRIALS. 99.
Add to list
Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium

Ine Wouters, Stefanie Desmet, Liesbet Van Heirstraeten, Stéphanie Blaizot, Jan Verhaegen, Pierre Van Damme, Surbhi Malhotra-Kumar, Heidi Theeten, th NPcariage Study Group and Koen Van Herck (UGent)

(2019) VACCINE. 37(8). p.1080-1086
Add to list
- Journal Article
- A1
- open access
The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006 : a comparative analysis with hepatitis A virus seroprevalence

Suzanne Smit, Steven Abrams, Pierre Dorny (UGent) , Niko Speybroeck, Brecht Devleesschauwer (UGent) , Veronik Hutse, Hilde Jansens, Heidi Theeten, Philippe Beutels and Niel Hens

(2019) EPIDEMIOLOGY AND INFECTION. 147.
Add to list
- Journal Article
- A1
- open access
Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme

Ine Wouters, Liesbet Van Heirstraeten, Stefanie Desmet, Stéphanie Blaizot, Jan Verhaegen, Herman Goossens, Pierre Van Damme, Surbhi Malhotra-Kumar, Heidi Theeten, the NPcarriage study group, et al.

(2018) VACCINE. 36(1). p.15-22
Add to list
- Journal Article
- A1
- open access
Long-term antibody persistence after vaccination with a 2-dose Havrix™ (inactivated hepatitis A vaccine) : 20 years of observed data, and long-term model-based predictions

Heidi Theeten, Koen Van Herck (UGent) , Olivier Van Der Meeren, Priya Crasta, Pierre Van Damme and Niel Hens

(2015) VACCINE. 33(42). p.5723-5727
Add to list
Lessons learned from a measles outbreak in Antwerp, Belgium 2007-2008

Carine Asnong, Koen Van Herck (UGent) , Tinne Lernout, Heidi Theeten and Pierre Van Damme

(2011) PEDIATRIC INFECTIOUS DISEASE JOURNAL. 30(4). p.343-345

Academic Bibliography

COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020

How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018

Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic : perspective from a European country

Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium

The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006 : a comparative analysis with hepatitis A virus seroprevalence

Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme

Long-term antibody persistence after vaccination with a 2-dose Havrix™ (inactivated hepatitis A vaccine) : 20 years of observed data, and long-term model-based predictions

Lessons learned from a measles outbreak in Antwerp, Belgium 2007-2008

Contents

Support

Contact

COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020

How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018

Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic : perspective from a European country

Follow-up of serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae in child carriage after a PCV13-to-PCV10 vaccine switch in Belgium

The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006 : a comparative analysis with hepatitis A virus seroprevalence

Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme

Long-term antibody persistence after vaccination with a 2-dose Havrix™ (inactivated hepatitis A vaccine) : 20 years of observed data, and long-term model-based predictions

Lessons learned from a measles outbreak in Antwerp, Belgium 2007-2008

Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme